Skip to main content
Top
Published in: Journal of Experimental & Clinical Cancer Research 1/2014

Open Access 01-12-2014 | Research

Aquaporin 3 promotes epithelial-mesenchymal transition in gastric cancer

Authors: Jia Chen, Tao Wang, Yang-Chun Zhou, Fei Gao, Zhi-Hong Zhang, Hao Xu, Shou-Lin Wang, Li-Zong Shen

Published in: Journal of Experimental & Clinical Cancer Research | Issue 1/2014

Login to get access

Abstract

Background

Gastric carcinoma (GC) is a common and lethal malignancy, and epithelial-mesenchymal transition (EMT) is believed to contribute to invasive and metastatic tumor growth. Aquaporin 3 (AQP3) is overexpressed in human GC tissues, while human epidermal growth factor (EGF) and hepatocyte growth factor, which can induce EMT, are able to up-regulate AQP3 expression, subsequently promoting GC cell migration and proliferation. The purpose of this study was to investigate the effects of AQP3 on EMT in human GC.

Methods

AQP3 and EMT-related proteins were detected by immunohistochemistry in human GC specimens and their clinical significance evaluated. AQP3 knockdown was attempted using small interfering RNAs, while EGF was used to up-regulate AQP3 expression. Western blotting, real-time quantitative polymerase chain reaction assays and immunofluorescence were used to evaluate changes in expression of AQP3 and EMT-related proteins in the SGC7901 and MGC803 human GC cell lines.

Results

AQP3 up-expression was associated with EMT-related proteins in human GC specimens, which correlated with poor prognosis for GC. AQP3 modulated GC cell proliferation, migration and invasion in vitro, and induced E-cadherin repression. AQP3 also up-regulated the expression of vimentin and fibronectin in vitro. The PI3K/AKT/SNAIL signaling pathway was likely involved in the induction of EMT by AQP3 in GC.

Conclusions

AQP3 promotes EMT in human cases of GC, allowing us to understand the mechanisms of AQP3 in GC progression, thus providing a potential strategy for its treatment.
Appendix
Available only for authorised users
Literature
1.
go back to reference Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D: Global cancer statistics. CA Cancer J Clin. 2011, 61: 69-90. 10.3322/caac.20107.CrossRefPubMed Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D: Global cancer statistics. CA Cancer J Clin. 2011, 61: 69-90. 10.3322/caac.20107.CrossRefPubMed
2.
go back to reference Catalano V, Labianca R, Beretta GD, Gatta G, de Braud F, Van Cutsem E: Gastric cancer. Crit Rev Oncol Hematol. 2009, 71: 127-164. 10.1016/j.critrevonc.2009.01.004.CrossRefPubMed Catalano V, Labianca R, Beretta GD, Gatta G, de Braud F, Van Cutsem E: Gastric cancer. Crit Rev Oncol Hematol. 2009, 71: 127-164. 10.1016/j.critrevonc.2009.01.004.CrossRefPubMed
3.
go back to reference Fidler IJ: The pathogenesis of cancer metastasis: the ‘seed and soil’ hypothesis revisited. Nat Rev Cancer. 2003, 3: 453-458. 10.1038/nrc1098.CrossRefPubMed Fidler IJ: The pathogenesis of cancer metastasis: the ‘seed and soil’ hypothesis revisited. Nat Rev Cancer. 2003, 3: 453-458. 10.1038/nrc1098.CrossRefPubMed
4.
go back to reference Singh A, Settleman J: EMT cancer stem cells and drug resistance: an emerging axis of evil in the war on cancer. Oncogene. 2010, 29: 4741-4751. 10.1038/onc.2010.215.PubMedCentralCrossRefPubMed Singh A, Settleman J: EMT cancer stem cells and drug resistance: an emerging axis of evil in the war on cancer. Oncogene. 2010, 29: 4741-4751. 10.1038/onc.2010.215.PubMedCentralCrossRefPubMed
5.
go back to reference Yoon CH, Kim MJ, Lee H, Kim RK, Lim EJ, Yoo KC, Lee GH, Cui YH, Oh YS, Gye MC, Lee YY, Park IC, An S, Hwang SG, Park MJ, Suh Y, Lee SJ: PTTG1 promotes tumor malignancy via epithelial to mesenchymal transition and expansion of cancer stem cell population. J Biol Chem. 2012, 287: 19516-19527. 10.1074/jbc.M111.337428.PubMedCentralCrossRefPubMed Yoon CH, Kim MJ, Lee H, Kim RK, Lim EJ, Yoo KC, Lee GH, Cui YH, Oh YS, Gye MC, Lee YY, Park IC, An S, Hwang SG, Park MJ, Suh Y, Lee SJ: PTTG1 promotes tumor malignancy via epithelial to mesenchymal transition and expansion of cancer stem cell population. J Biol Chem. 2012, 287: 19516-19527. 10.1074/jbc.M111.337428.PubMedCentralCrossRefPubMed
6.
go back to reference Huang J, Xiao D, Li G, Ma J, Chen P, Yuan W, Hou F, Ge J, Zhong M, Tang Y, Xia X, Chen Z: EphA2 promotes epithelial-mesenchymal transition through the Wnt/β-catenin pathway in gastric cancer cells. Oncogene. 2013, doi:10.1038/onc.2013.238 Huang J, Xiao D, Li G, Ma J, Chen P, Yuan W, Hou F, Ge J, Zhong M, Tang Y, Xia X, Chen Z: EphA2 promotes epithelial-mesenchymal transition through the Wnt/β-catenin pathway in gastric cancer cells. Oncogene. 2013, doi:10.1038/onc.2013.238
7.
go back to reference Polyak K, Weinberg RA: Transitions between epithelial and mesenchymal states: acquisition of malignant and stem cell traits. Nat Rev Cancer. 2009, 9: 265-273. 10.1038/nrc2620.CrossRefPubMed Polyak K, Weinberg RA: Transitions between epithelial and mesenchymal states: acquisition of malignant and stem cell traits. Nat Rev Cancer. 2009, 9: 265-273. 10.1038/nrc2620.CrossRefPubMed
8.
go back to reference Thiery JP, Acloque H, Huang RY, Nieto MA: Epithelial-mesenchymal transitions in development and disease. Cell. 2009, 139: 871-890. 10.1016/j.cell.2009.11.007.CrossRefPubMed Thiery JP, Acloque H, Huang RY, Nieto MA: Epithelial-mesenchymal transitions in development and disease. Cell. 2009, 139: 871-890. 10.1016/j.cell.2009.11.007.CrossRefPubMed
10.
go back to reference Tiwari N, Gheldof A, Tatari M, Christofori G: EMT as the ultimate survival mechanism of cancer cells. Semin Cancer Biol. 2012, 22: 194-207. 10.1016/j.semcancer.2012.02.013.CrossRefPubMed Tiwari N, Gheldof A, Tatari M, Christofori G: EMT as the ultimate survival mechanism of cancer cells. Semin Cancer Biol. 2012, 22: 194-207. 10.1016/j.semcancer.2012.02.013.CrossRefPubMed
11.
go back to reference Imbert A-M, Garulli C, Choquet E, Koubi M, Aurrand-Lions M, Chabannon C: CD146 expression in human breast cancer cell lines induces phenotypic and functional changes observed in epithelial to mesenchymal transition. PLoS One. 2012, 7: e43752-10.1371/journal.pone.0043752.PubMedCentralCrossRefPubMed Imbert A-M, Garulli C, Choquet E, Koubi M, Aurrand-Lions M, Chabannon C: CD146 expression in human breast cancer cell lines induces phenotypic and functional changes observed in epithelial to mesenchymal transition. PLoS One. 2012, 7: e43752-10.1371/journal.pone.0043752.PubMedCentralCrossRefPubMed
13.
go back to reference Hu J, Verkman AS: Increased migration and metastatic potential of tumor cells expressing aquaporin water channels. Faseb J. 2006, 20: 1892-1894. 10.1096/fj.06-5930fje.CrossRefPubMed Hu J, Verkman AS: Increased migration and metastatic potential of tumor cells expressing aquaporin water channels. Faseb J. 2006, 20: 1892-1894. 10.1096/fj.06-5930fje.CrossRefPubMed
14.
15.
go back to reference Hara-Chikuma M, Verkman AS: Aquaporin-3 facilitates epidermal cell migration and proliferation during wound healing. J Mol Med (Berl). 2008, 86: 221-231. 10.1007/s00109-007-0272-4.CrossRef Hara-Chikuma M, Verkman AS: Aquaporin-3 facilitates epidermal cell migration and proliferation during wound healing. J Mol Med (Berl). 2008, 86: 221-231. 10.1007/s00109-007-0272-4.CrossRef
16.
go back to reference Shen L, Zhu Z, Huang Y, Shu Y, Sun M, Xu H, Zhang G, Guo R, Wei W, Wu W: Expression profile of multiple aquaporins in human gastric carcinoma and its clinical significance. Biomed Pharmacother. 2010, 64: 313-318.CrossRefPubMed Shen L, Zhu Z, Huang Y, Shu Y, Sun M, Xu H, Zhang G, Guo R, Wei W, Wu W: Expression profile of multiple aquaporins in human gastric carcinoma and its clinical significance. Biomed Pharmacother. 2010, 64: 313-318.CrossRefPubMed
17.
go back to reference Huang Y, Zhu Z, Sun M, Wang J, Guo R, Shen L, Wu W: Critical role of Aquaporin-3 in the human epidermal growth factor-induced migration and proliferation in the human gastric adenocarcinoma cells. Cancer Biol Ther. 2010, 9: 1000-1007. 10.4161/cbt.9.12.11705.CrossRefPubMed Huang Y, Zhu Z, Sun M, Wang J, Guo R, Shen L, Wu W: Critical role of Aquaporin-3 in the human epidermal growth factor-induced migration and proliferation in the human gastric adenocarcinoma cells. Cancer Biol Ther. 2010, 9: 1000-1007. 10.4161/cbt.9.12.11705.CrossRefPubMed
18.
go back to reference Wang J, Gui Z, Deng L, Sun M, Guo R, Zhang W, Shen L: c-Met upregulates aquaporin 3 expression in human gastric carcinoma cells via the ERK signalling pathway. Cancer Lett. 2012, 319: 109-117. 10.1016/j.canlet.2011.12.040.CrossRefPubMed Wang J, Gui Z, Deng L, Sun M, Guo R, Zhang W, Shen L: c-Met upregulates aquaporin 3 expression in human gastric carcinoma cells via the ERK signalling pathway. Cancer Lett. 2012, 319: 109-117. 10.1016/j.canlet.2011.12.040.CrossRefPubMed
19.
go back to reference Ogunwobi OO, Liu C: Hepatocyte growth factor upregulation promotes carcinogenesis and epithelial-mesenchymal transition in hepatocellular carcinoma via Akt and COX-2 pathways. Clin Exp Metastasis. 2011, 28: 721-731. 10.1007/s10585-011-9404-x.PubMedCentralCrossRefPubMed Ogunwobi OO, Liu C: Hepatocyte growth factor upregulation promotes carcinogenesis and epithelial-mesenchymal transition in hepatocellular carcinoma via Akt and COX-2 pathways. Clin Exp Metastasis. 2011, 28: 721-731. 10.1007/s10585-011-9404-x.PubMedCentralCrossRefPubMed
20.
go back to reference Ludwig K, Tse ES, Wang JY: Colon cancer cells adopt an invasive phenotype without mesenchymal transition in 3-D but not 2-D culture upon combined stimulation with EGF and crypt growth factors. BMC Cancer. 2013, 13: 221-10.1186/1471-2407-13-221.PubMedCentralCrossRefPubMed Ludwig K, Tse ES, Wang JY: Colon cancer cells adopt an invasive phenotype without mesenchymal transition in 3-D but not 2-D culture upon combined stimulation with EGF and crypt growth factors. BMC Cancer. 2013, 13: 221-10.1186/1471-2407-13-221.PubMedCentralCrossRefPubMed
21.
go back to reference Xu H, Xu Y, Zhang W, Shen L, Yang L, Xu Z: Aquaporin-3 positively regulates matrix metalloproteinases via PI3K/AKT signal pathway in human gastric carcinoma SGC7901 cells. J Exp Clin Cancer Res. 2011, 30: 86-10.1186/1756-9966-30-86. doi:10.1186/1756-9966-30-86PubMedCentralCrossRefPubMed Xu H, Xu Y, Zhang W, Shen L, Yang L, Xu Z: Aquaporin-3 positively regulates matrix metalloproteinases via PI3K/AKT signal pathway in human gastric carcinoma SGC7901 cells. J Exp Clin Cancer Res. 2011, 30: 86-10.1186/1756-9966-30-86. doi:10.1186/1756-9966-30-86PubMedCentralCrossRefPubMed
22.
go back to reference Fanelli MF, Chinen LT, Begnami MD, Costa WL, Fregnami JH, Soares FA, Montagnini AL: The influence of transforming growth factor-α, cyclooxygenase-2, matrix metalloproteinase (MMP)-7, MMP-9 and CXCR4 proteins involved in epithelial-mesenchymal transition on overall survival of patients with gastric cancer. Histopathology. 2012, 61: 153-161. 10.1111/j.1365-2559.2011.04139.x.CrossRefPubMed Fanelli MF, Chinen LT, Begnami MD, Costa WL, Fregnami JH, Soares FA, Montagnini AL: The influence of transforming growth factor-α, cyclooxygenase-2, matrix metalloproteinase (MMP)-7, MMP-9 and CXCR4 proteins involved in epithelial-mesenchymal transition on overall survival of patients with gastric cancer. Histopathology. 2012, 61: 153-161. 10.1111/j.1365-2559.2011.04139.x.CrossRefPubMed
23.
go back to reference Wang G, Gao F, Zhang W, Chen J, Wang T, Zhang G, Shen L: Involvement of Aquaporin 3 in helicobacter pylori-related gastric diseases. PLoS One. 2012, 7: e49104-10.1371/journal.pone.0049104.PubMedCentralCrossRefPubMed Wang G, Gao F, Zhang W, Chen J, Wang T, Zhang G, Shen L: Involvement of Aquaporin 3 in helicobacter pylori-related gastric diseases. PLoS One. 2012, 7: e49104-10.1371/journal.pone.0049104.PubMedCentralCrossRefPubMed
24.
go back to reference Kachroo P, Lee MH, Zhang L, Baratelli F, Lee G, Srivastava MK, Wang G, Walser TC, Krysan K, Sharma S, Dubinett SM, Lee JM: IL-27 inhibits epithelial-mesenchymal transition and angiogenic factor production in a STAT1-dominant pathway in human non-small cell lung cancer. J Exp Clin Cancer Res. 2013, 32: 97-10.1186/1756-9966-32-97. doi:10.1186/1756-9966-32-97PubMedCentralCrossRefPubMed Kachroo P, Lee MH, Zhang L, Baratelli F, Lee G, Srivastava MK, Wang G, Walser TC, Krysan K, Sharma S, Dubinett SM, Lee JM: IL-27 inhibits epithelial-mesenchymal transition and angiogenic factor production in a STAT1-dominant pathway in human non-small cell lung cancer. J Exp Clin Cancer Res. 2013, 32: 97-10.1186/1756-9966-32-97. doi:10.1186/1756-9966-32-97PubMedCentralCrossRefPubMed
25.
go back to reference Tsubaki M, Komai M, Fujimoto S, Itoh T, Imano M, Sakamoto K, Shimaoka H, Takeda T, Ogawa N, Mashimo K, Fujiwara D, Mukai J, Sakaguchi K, Satou T, Nishida S: Activation of NF-κB by the RANKL/RANK system up-regulates snail and twist expressions and induces epithelial-to-mesenchymal transition in mammary tumor cell lines. J Exp Clin Cancer Res. 2013, 32: 62-10.1186/1756-9966-32-62. doi:10.1186/1756-9966-32-62PubMedCentralCrossRefPubMed Tsubaki M, Komai M, Fujimoto S, Itoh T, Imano M, Sakamoto K, Shimaoka H, Takeda T, Ogawa N, Mashimo K, Fujiwara D, Mukai J, Sakaguchi K, Satou T, Nishida S: Activation of NF-κB by the RANKL/RANK system up-regulates snail and twist expressions and induces epithelial-to-mesenchymal transition in mammary tumor cell lines. J Exp Clin Cancer Res. 2013, 32: 62-10.1186/1756-9966-32-62. doi:10.1186/1756-9966-32-62PubMedCentralCrossRefPubMed
26.
go back to reference Corso G, Carvalho J, Marrelli D, Vindigni C, Carvalho B, Seruca R, Roviello F, Oliveira C: Somatic mutations and deletions of the E-cadherin gene predict poor survival of patients with gastric cancer. J Clin Oncol. 2013, 31: 868-875. 10.1200/JCO.2012.44.4612.CrossRefPubMed Corso G, Carvalho J, Marrelli D, Vindigni C, Carvalho B, Seruca R, Roviello F, Oliveira C: Somatic mutations and deletions of the E-cadherin gene predict poor survival of patients with gastric cancer. J Clin Oncol. 2013, 31: 868-875. 10.1200/JCO.2012.44.4612.CrossRefPubMed
Metadata
Title
Aquaporin 3 promotes epithelial-mesenchymal transition in gastric cancer
Authors
Jia Chen
Tao Wang
Yang-Chun Zhou
Fei Gao
Zhi-Hong Zhang
Hao Xu
Shou-Lin Wang
Li-Zong Shen
Publication date
01-12-2014
Publisher
BioMed Central
Published in
Journal of Experimental & Clinical Cancer Research / Issue 1/2014
Electronic ISSN: 1756-9966
DOI
https://doi.org/10.1186/1756-9966-33-38

Other articles of this Issue 1/2014

Journal of Experimental & Clinical Cancer Research 1/2014 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine